Dark

Check out our Level2View

RHHVF
ROCHE HLDG DIV RTS
stock OTC

EOD

Apr 17, 2026

405.00USD-2.051%(-8.48)778

Pre-market

0.00USD-100.000%(-413.48)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 31, 2022

05:44AM EST FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo Benzinga

Jan 25, 2022

12:19PM EST Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months Benzinga

Dec 15, 2021

07:59AM EST After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial Benzinga

Dec 13, 2021

08:55AM EST Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings Benzinga

Dec 10, 2021

11:26AM EST Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial Benzinga

07:55AM EST Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer Benzinga

Dec 7, 2021

07:46AM EST Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19 Benzinga

Dec 3, 2021

08:55AM EST Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests Benzinga

Nov 19, 2021

02:12PM EST Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer Benzinga

Nov 18, 2021

07:51AM EST Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes Benzinga

Nov 12, 2021

01:13PM EST Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail Benzinga

Nov 11, 2021

02:04PM EST EU Regulator Backs Regeneron-Roche's COVID-19 Drug Benzinga

Nov 10, 2021

12:37PM EST Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters Benzinga

Nov 8, 2021

09:46AM EST Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose Benzinga

Nov 4, 2021

07:34AM EDT Novartis To Offload Its Stake Back To Roche For $20.7B Benzinga

Nov 2, 2021

11:26AM EDT Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting Benzinga

Oct 21, 2021

12:10PM EDT Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics Benzinga

12:10PM EDT AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial Benzinga

Oct 18, 2021

12:56PM EDT Roche's Tecentriq Wins FDA Approval In Adjuvant Lung Cancer Setting Benzinga

Oct 1, 2021

11:50AM EDT Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection Benzinga

Sep 30, 2021

07:15AM EDT Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail Benzinga

Sep 27, 2021

04:00PM EDT Glaxo - Vir Biotech's COVID Treatment Approved In Japan Benzinga

05:53AM EDT Acceleron In Advanced $11B Buyout Talks: Bloomberg Benzinga

Sep 24, 2021

01:29PM EDT Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients Benzinga

01:19PM EDT WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access Benzinga

Sep 15, 2021

03:08PM EDT Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know Benzinga

Sep 14, 2021

08:34AM EDT Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer Benzinga

Sep 9, 2021

07:10AM EDT Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition Benzinga

Sep 7, 2021

06:55AM EDT Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy Benzinga

Aug 27, 2021

02:03PM EDT After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US Benzinga

Aug 24, 2021

11:41AM EDT Shape Therapeutics, Roche Form $3B RNA Editing Collaboration Benzinga

Aug 20, 2021

09:47AM EDT UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail Benzinga

Aug 17, 2021

01:44PM EDT Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage Benzinga

Aug 9, 2021

04:06PM EDT AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast Cancer Benzinga

07:11AM EDT Genentech's Polivy Plus R-CHP Shows Prolonged Survival In Newly Diagnosed DLBCL Patients Benzinga

Aug 3, 2021

06:32AM EDT Roche's Tecentriq As Adjuvant Treatment Under Priority Review With FDA For Early Lung Cancer Benzinga

Aug 2, 2021

06:03AM EDT FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis Benzinga

Jul 29, 2021

08:04AM EDT Roche's Faricimab US Application For Ocular Diseases Under Priority Review Benzinga

Jul 27, 2021

11:13AM EDT Infinity Pharma Stock Drops After Updated Data From Bladder & Breast Cancer Trials, Q2 Earnings Benzinga

Jul 22, 2021

01:31PM EDT Roche Puts Alzheimer's Candidate, Gantenerumab In Spotlight; In Dialogue with FDA: Reuters Benzinga

07:07AM EDT Rebound In COVID-19 Tests Lift Roche's Half-Year Sales, Oncology Still Hit By Biosimilars, Pandemic Benzinga

Jul 21, 2021

12:00PM EDT Spark Therapeutics' Hemophilia Gene Therapy Achieve Stable, Durable FVIII Expression Benzinga

05:59AM EDT AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic Syndromes Benzinga

Jul 19, 2021

08:18AM EDT Roche Unveils New Hemlibra Data Reinforcing Safety Profile In Hemophilia A Benzinga

Jul 12, 2021

06:12AM EDT Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159 Benzinga

Jul 7, 2021

11:47AM EDT WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients Benzinga

Jun 30, 2021

11:11AM EDT Atea Pharma's AT-527 Rapidly Reduces Viral Load Levels In Hospitalized COVID-19 Patients Benzinga

Jun 29, 2021

03:17PM EDT Novartis Claims It Overpaid Genentech $210M In Patent Licensing Pact Benzinga

Jun 28, 2021

08:30AM EDT Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder Benzinga

Jun 25, 2021

08:19AM EDT FDA Gives Emergency Use Nod For Roche's Arthritis Drug Against Severe COVID-19 Benzinga

Jun 22, 2021

06:58AM EDT Roche's Alzheimer's Antibody Reduces Associated Biomarkers In Subset Of AD Patients, Study Shows Benzinga

Jun 18, 2021

01:27PM EDT Roche's New COVID-19 Point Of Care Test Scores FDA Emergency Use Nod Benzinga

Jun 17, 2021

10:32AM EDT Amneal's Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer Benzinga

10:26AM EDT Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy Benzinga

Jun 16, 2021

09:26AM EDT Atea Pharma Secures AT-527-Related Milestone Payment Of $50M From Roche Benzinga

Jun 14, 2021

09:42AM EDT AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment Benzinga

07:32AM EDT JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients Benzinga

Jun 11, 2021

10:11AM EDT AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment Benzinga

Jun 7, 2021

08:31AM EDT Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab Benzinga

Jun 4, 2021

10:05AM EDT Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer Benzinga

Jun 1, 2021

12:30PM EDT Biogen, Bio-Thera's Biosimilar Referencing Tocilizumab Meets Primary Endpoints In Late-Stage Study Benzinga

May 25, 2021

11:28AM EDT AbbVie-Roche Win European Approval for Venclyxto in Newly Diagnosed Acute Myeloid Leukemia Benzinga

11:06AM EDT Pieris Stock Surges on Development Pact with Genentech for Respiratory, Ophthalmology Settings Benzinga

07:50AM EDT Exelixis' Cabometyx, Roche's Tecentriq Combo Achieves 27% ORR in High-Risk Prostate Cancer Patients Benzinga

May 20, 2021

06:17AM EDT I-Mab Showcases Early Data On Uliledlimab/Atezolizumab Combo In Advanced Cancer Settings Benzinga

May 18, 2021

06:37AM EDT Roche's Cobas COVID Test Scores EUA For Asymptomatic People Benzinga

May 11, 2021

06:57AM EDT Prothena Receives $60M Milestone Payment After Parkinson's Candidate Moves Forward In Mid-Stage Study With Dosing Benzinga

May 5, 2021

09:27AM EDT India Gives Emergency Use Nod To Roche-Regeneron's COVID-19 Antibody Cocktail Benzinga

Apr 29, 2021

11:47AM EDT Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer Benzinga

06:44AM EDT Atea Pharma Stock Is Trading Higher As AT-527 Study In COVID-19 Moves Forward With Dosing Benzinga

Apr 28, 2021

09:17AM EDT FDA Oncology Adcomm Votes To Keep Conditional Approval For Roche's Tecentriq In Place For Now Benzinga

Apr 23, 2021

02:36PM EDT Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion Benzinga

Apr 21, 2021

06:32AM EDT Roche Backs 2021 Outlook Despite Lackluster Q1 Performance In Pharmaceuticals Division Benzinga

Apr 12, 2021

10:19AM EDT Cardiff Oncology's Onvansertib Shows Durable Response, Progression-Free Survival In Colorectal Cancer Patients Benzinga

Mar 30, 2021

07:06AM EDT PTC Therapeutics-Roche's Evrysdi Approved In Europe For Muscular Atrophy Benzinga

Mar 29, 2021

09:36AM EDT Tempest Therapeutics To Go Public Via Millendo Therapeutics Merger Benzinga

Mar 23, 2021

01:05PM EDT Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug Benzinga

06:57AM EDT Regeneron's Lower Dose Of COVID-19 Antibody Cocktail Cuts Hospitalization, Death By 70% Benzinga

06:54AM EDT Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen Benzinga

Mar 11, 2021

06:37AM EST Roche's Tocilizumab, Gilead's Remdesivir Combo Fails To Improve Hospital Discharge Time in COVID-19 Study Benzinga

Mar 9, 2021

09:16AM EST FDA Ok's Roche's Companion Diagnostic For Pfizer's Lorbrena In Lung Cancer Benzinga

Mar 8, 2021

07:01AM EST Roche Walks Away From Regular FDA Nod For Tecentriq In Pretreated Bladder Cancer Benzinga

Mar 2, 2021

08:09AM EST OTC Markets Group On The Importance Of Investor Relations During A Pandemic Benzinga

Feb 26, 2021

01:02PM EST Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion Benzinga

Feb 25, 2021

01:46PM EST Roche Reports Positive Evrysdi Data From Dose-Finding Part Of Spinal Muscular Atrophy Trial Benzinga

Feb 24, 2021

07:21AM EST Opthea Outlines OPT-302 Pivotal Study Designs In Chronic Eye Disorder Benzinga

Feb 12, 2021

12:16PM EST Roche's Faricimab On Par With Rival Regeneron's Aflibercept In Four Late-Stage Studies In Vision Loss Disorder Benzinga

Feb 11, 2021

12:04PM EST Oxford Researchers Say Roche's Arthritis Drug Cuts Death In Hospitalized COVID-19 Patients Benzinga

Feb 5, 2021

12:37PM EST Roche Unit Spark Therapeutics' Hemophilia A Gene Therapy Shows Durable Benefit In Early-Stage Study Benzinga

Feb 4, 2021

07:31AM EST COVID-19 Test Business Fuels Roche Q4 Sales, Hikes Dividend Benzinga

Feb 3, 2021

08:43AM EST Affimed Partners With Roche To Develop AFM24 Combo Therapy In EGFR Expressing Solid Tumors Benzinga

Share